Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1489964

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1489964

Europe Inhalation Anesthesia Market Size study, by Type (Desflurane, Sevoflurane, Isoflurane, and Other Types), by End-User (Hospital, Ambulatory Surgical Centers, Other End Users), and Country Forecasts 2022-2032

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Europe Inhalation Anesthesia Market is valued at approximately USD 320 million in 2023 and is anticipated to grow with a healthy growth rate of more than 9.0% over the forecast period 2024-2032. Inhalation anesthesia involves administering volatile anesthetic agents through inhalation to induce and maintain general anesthesia during surgeries, ensuring patient comfort and safety. A significant trend in this market is the heightened emphasis on enhancing patient safety and experience, leading to the development of advanced anesthesia delivery systems and agents with improved safety profiles. Technological advancements, such as closed-loop anesthesia systems and intelligent monitoring devices, are further augmenting the precision and effectiveness of anesthesia administration. Additionally, the increasing demand for minimally invasive surgeries and outpatient procedures is driving the adoption of inhalation anesthesia due to its fast onset and recovery times. These factors collectively shape the evolving landscape of the Inhalation Anesthesia Market, reflecting a growing commitment to advancing surgical care while prioritizing patient well-being.

Continuous technological advancements in anesthesia delivery systems, such as smart monitoring devices and closed-loop anesthesia systems, are driving the growth of the Inhalation Anesthesia Market. These innovations enhance the safety, precision, and efficiency of anesthesia administration, leading to improved patient outcomes and surgical experiences. Concurrently, the increasing demand for surgical procedures, including minimally invasive surgeries and outpatient interventions, contributes to the rising utilization of inhalation anesthesia. Also, ongoing research and development efforts to enhance the safety, efficacy, and accessibility of inhalation anesthesia while addressing regulatory and economic constraints. However, stringent regulatory requirements for drug approval, pricing pressures within healthcare systems, and potential adverse effects associated with prolonged anesthesia exposure, on the other hand, stifle Inhalation Anesthesia market growth between 2022 and 2032.

The key countries considered for the Europe Inhalation Anesthesia market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany emerged as a leading country. Renowned for its advanced healthcare infrastructure, robust research and development capabilities, and high standards of patient care, Germany demonstrates significant demand for inhalation anesthesia products. The country's aging population, coupled with a rising prevalence of chronic diseases and increasing surgical volumes, drives the demand for anesthesia services, including inhalation anesthesia. Moreover, Germany's regulatory environment and healthcare policies support the adoption of innovative medical technologies, further propelling market growth. With a strong emphasis on patient safety, technological advancement, and healthcare accessibility, Germany plays a pivotal role in shaping the landscape of the Inhalation Anesthesia Market in Europe.

Major market player included in this report are:

  • AbbVie Inc.
  • Baxter International Inc.
  • B. Braun Melsungen
  • Pfizer Inc.
  • Fresenius SE & Co. KGaA
  • Aspen Pharmacare Holdings Limited
  • F. Hoffmann-La Roche AG
  • Piramal Group
  • Viatris Inc. (Mylan NV)
  • Teva Pharmaceutical Industries Ltd

By Type

  • Desflurane
  • Sevoflurane
  • Isoflurane
  • Other Types

By End-user

  • Hospital,
  • Ambulatory Surgical Centers
  • Other End Users

By Region:

  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and Country level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Europe Inhalation Aesthesia Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Europe Inhalation Aesthesia Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Type
    • 2.3.2. By End-user
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Europe Inhalation Aesthesia Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Europe Inhalation Aesthesia Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Europe Inhalation Aesthesia Market Size & Forecasts by Type 2022-2032

  • 5.1. Desflurane
  • 5.2. Sevoflurane
  • 5.3. Isoflurane
  • 5.4. Other Types

Chapter 6. Europe Inhalation Aesthesia Market Size & Forecasts by End-user 2022-2032

  • 6.1. Hospital,
  • 6.2. Ambulatory Surgical Centers
  • 6.3. Other End Users

Chapter 7. Europe Inhalation Aesthesia Market Size & Forecasts by Country 2022-2032

  • 7.1. U.K. Inhalation Aesthesia Market
    • 7.1.1. Type breakdown size & forecasts, 2022-2032
    • 7.1.2. End-user breakdown size & forecasts, 2022-2032
  • 7.2. Germany Inhalation Aesthesia Market
  • 7.3. France Inhalation Aesthesia Market
  • 7.4. Spain Inhalation Aesthesia Market
  • 7.5. Italy Inhalation Aesthesia Market
  • 7.6. Rest of Europe Inhalation Aesthesia Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Aspen Pharmacare Holdings Limited
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. AbbVie Inc.
    • 8.3.3. Baxter International Inc.
    • 8.3.4. B. Braun Melsungen
    • 8.3.5. Pfizer Inc.
    • 8.3.6. Fresenius SE & Co. KGaA
    • 8.3.7. F. Hoffmann-La Roche AG
    • 8.3.8. Piramal Group
    • 8.3.9. Viatris Inc. (Mylan NV)
    • 8.3.10. Teva Pharmaceutical Industries Ltd

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes

LIST OF TABLES

  • TABLE 1. Europe Inhalation Aesthesia market, report scope
  • TABLE 2. Europe Inhalation Aesthesia market estimates & forecasts by Country 2022-2032 (USD Million)
  • TABLE 3. Europe Inhalation Aesthesia market estimates & forecasts by Type 2022-2032 (USD Million)
  • TABLE 4. Europe Inhalation Aesthesia market estimates & forecasts by End-user 2022-2032 (USD Million)
  • TABLE 5. Europe Inhalation Aesthesia market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 6. Europe Inhalation Aesthesia market by country, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 7. Europe Inhalation Aesthesia market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 8. Europe Inhalation Aesthesia market by country, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 9. Europe Inhalation Aesthesia market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 10. Europe Inhalation Aesthesia market by country, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 11. Europe Inhalation Aesthesia market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 12. Europe Inhalation Aesthesia market by country, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 13. Europe Inhalation Aesthesia market by segment, estimates & forecasts, 2022-2032 (USD Million) Europe Inhalation Aesthesia market by country, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 14. UK Inhalation Aesthesia market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 15. UK Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 16. UK Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 17. Germany Inhalation Aesthesia market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 18. Germany Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 19. Germany Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 20. France Inhalation Aesthesia market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 21. France Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 22. France Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 23. Italy Inhalation Aesthesia market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 24. Italy Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 25. Italy Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 26. Spain Inhalation Aesthesia market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 27. Spain Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 28. Spain Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 29. RoE Inhalation Aesthesia market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 30. RoE Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 31. RoE Inhalation Aesthesia market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 32. List of secondary sources, used in the study of Europe Inhalation Aesthesia Market.
  • TABLE 33. List of primary sources, used in the study of Europe Inhalation Aesthesia Market.
  • TABLE 34. Years considered for the study.
  • TABLE 35. Exchange rates considered.

LIST OF FIGURES

  • FIG 1. Europe Inhalation Aesthesia market, research methodology
  • FIG 2. Europe Inhalation Aesthesia market, market estimation techniques
  • FIG 3. Europe market size estimates & forecast methods.
  • FIG 4. Europe Inhalation Aesthesia market, key trends 2023
  • FIG 5. Europe Inhalation Aesthesia market, growth prospects 2022-2032
  • FIG 6. Europe Inhalation Aesthesia market, porters 5 force model
  • FIG 7. Europe Inhalation Aesthesia market, pestel analysis
  • FIG 8. Europe Inhalation Aesthesia market, value chain analysis
  • FIG 9. Europe Inhalation Aesthesia market by segment, 2022 & 2032 (USD Million)
  • FIG 10. Europe Inhalation Aesthesia market by segment, 2022 & 2032 (USD Million)
  • FIG 11. Europe Inhalation Aesthesia market by segment, 2022 & 2032 (USD Million)
  • FIG 12. Europe Inhalation Aesthesia market by segment, 2022 & 2032 (USD Million)
  • FIG 13. Europe Inhalation Aesthesia market by segment, 2022 & 2032 (USD Million)
  • FIG 14. Europe Inhalation Aesthesia market, Country snapshot 2022 & 2032
  • FIG 15. Europe Inhalation Aesthesia market 2022 & 2032 (USD Million)
  • FIG 16. Europe Inhalation Aesthesia market, company market share analysis (2023)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!